Amisulpride
SIGMA/A2729 - ≥98% (HPLC)
Synonym: 4-
CAS Number: 71675-85-9
Empirical Formula (Hill Notation): C17H27N3O4S
Molecular Weight: 369.48
EC Number: 275-831-7
MDL Number: MFCD00866691
Linear Formula: C17H27N3O4S
Product Type: Chemical
| assay | ≥98% (HPLC) |
| color | white |
| form | powder |
| InChI | 1S/C17H27N3O4S/c1-4-20-8- |
| InChI key | NTJOBXMMWNYJFB-UHFFFAOYSA |
| originator | Sanofi Aventis |
| Quality Level | 100 ![]() |
| SMILES string | O=C(NCC1CCCN1CC)C2=CC(S(= |
| storage condition | desiccated |
| protect from light | |
| storage temp. | 2-8°C |
| Application: | Amisulpride has been used as a dopamine receptor inhibitor to study its effects on diabetic bone abnormalities in mice. |
| Biochem/physiol Actions: | Amisulpride is a highly selective D2/D3 dopamine receptor antagonist and atypical antipsychotic. |
| Biochem/physiol Actions: | Amisulpride is a substituted benzamide derivative. It has a higher affinity towards dopamine receptors in limbic structures than the striatal structures. Amisulpride has a therapeutic effect against schizophrenia. |
| Features and Benefits: | This compound was developed by Sanofi Aventis . To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here . |
| Packaging: | 10, 50 mg in glass bottle |
| Symbol | GHS07 |
| Signal word | Warning |
| Hazard statements | H302 |
| Precautionary statements | P301 + P312 + P330 |
| Hazard Codes | Xn |
| Risk Statements | 22 |
| Safety Statements | 22-24/25 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% (HPLC) |
| Storage Temp. | 2-8°C |
| UNSPSC | 12352200 |


